|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03133832 |
|
Date of registration:
|
19/04/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium
|
|
Scientific title:
|
Efficacy of Chinese-made Versus WHO-PQ Praziquantel for Treatment of Schistosoma Haematobium in Zanzibar: a Randomized Controlled Trial |
|
Date of first enrolment:
|
April 10, 2017 |
|
Target sample size:
|
120 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03133832 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
|
Phase:
|
Phase 3
|
|
|
Countries of recruitment
|
|
Tanzania
| | | | | | | |
|
Contacts
|
|
Name:
|
Kun Yang, PHD |
|
Address:
|
|
|
Telephone:
|
+8613656190585 |
|
Email:
|
yangkun@jipd.com |
|
Affiliation:
|
|
|
|
Name:
|
Saleh Juma, Master |
|
Address:
|
|
|
Telephone:
|
+255 777 482 412 |
|
Email:
|
salehjuma2003@yahoo.com |
|
Affiliation:
|
|
|
|
Name:
|
Kun Yang, PHD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Jiangsu Institute of Parasitic Diseases |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Aged between 7 and 60 years old
- Study participants appear healthy at enrollment
- Suffering from S. haematobium infection, excreting eggs in urine
- Residing in Pemba island, Zanzibar
- Able to receive oral treatment
- Assent to participate in study
Exclusion Criteria:
- Pregnant or lactating at the time of the study
- Presence of severe illness or malnutrition
- Hypersensitivity to PZQ.
Age minimum:
7 Years
Age maximum:
60 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Schistosomiasis Haematobia
|
|
Intervention(s)
|
|
Drug: Companion Tablet
|
|
Primary Outcome(s)
|
|
The cure rate of the two treatment
[Time Frame: After one month]
|
|
Secondary Outcome(s)
|
|
The egg reduction of the two treatment
[Time Frame: After one month]
|
|
Secondary ID(s)
|
|
JIPD2017001
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|